American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT2 inhibitors and diabetic ketoacidosis
In clinical trials, it was found to control blood sugar levels in adults with type 2 diabetes by stimulating insulin, reducing glucagon, and slowing digestion
For patients with obstructive sleep apnea and obesity, Zepbound is the first and only medication approved by the FDA specifically to treat OSA
Semaglutide carries a boxed warning regarding thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
To make things still more complicated, your skin may react every time you take the medication and go out in the sun, or it may only happen once
examined the effects of onceweekly subcutaneous semaglutide (2.4 mg/week in SELECT, STEPHFpEF and STEPHFpEF DM